Antimicrobial resistance Biopharma selects StarDrop to guide discovery of next generation of antibiotics CAMBRIDGE, UK and BENGALURU, INDIA – Optibrium™, a developer of software for small molecule discovery, and Bugworks Research Inc. (Bugworks), a company focused on discovering biopharmaceuticals for the treatment of critical and serious bacterial infections, today announced the signing of a two-year agreement […]
Under novel collaboration approach, Schrödinger will autonomously lead discovery efforts; Takeda provides complementary structural biology support and has option to lead development and commercialization of licensed programs Osaka, Japan ＆ New York, NY – Takeda Pharmaceutical Company Limited (TSE: 4502) and Schrödinger Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, […]
Adds seamless link to compound structure assessment in 3D docking and alignment models CAMBRIDGE, UK – Optibrium, a developer of software for small molecule drug discovery, today announced the launch of version 6.4 of the StarDrop™ platform. The latest release includes a universal Pose Generation Interface, which seamlessly links expertly prepared docking and alignment models with […]
— Allows customers to easily find, procure MilliporeSigma products in the Reaxys interface — Reduces barriers for customers to develop new chemistries, accelerating research BILLERICA, Mass. — MilliporeSigma today announced a collaboration with Elsevier, the information analytics company specializing in science and health, to add its products into Reaxys, Elsevier’s chemistry database. Researchers and chemists who use […]
Provides MSc students with industry-relevant learning tools and pharma with a new pipeline of candidate compounds CAMBRIDGE, UK, LONDON UK, and GENEVA, Switzerland – Optibrium™, a developer of software for small molecule design and optimisation today announced it had entered into a collaboration with Imperial College London, the world leading science-based research institution and university, […]
HOBOKEN, NJ and COLUMBUS, OH— John Wiley and Sons, Inc. (NYSE:JWa) (NYSE:JWb), and CAS, a division of the American Chemical Society, today announced a partnership that will accelerate the evolution of predictive synthesis by enriching Wiley’s award-winning ChemPlanner technology with the most accurate and complete chemical information from CAS. Rapid advances in the fields of […]
– Revolutionary computer-aided retro-synthesis software optimizes productivity, organic synthesis – Complements MilliporeSigma’s leading e-commerce platform and chemistry portfolio of more than 400,000 building blocks, catalysts and reagents for chemical synthesis This image illustrates the synthetic pathways a researcher using Chematica might be given. Each burst represents the viable reaction options. The connections between the bursts […]
– Revolutionary computer-aided retro-synthesis software optimizes productivity, organic synthesis – Complements MilliporeSigma’s leading e-commerce platform and chemistry portfolio of more than 400,000 building blocks, catalysts and reagents for chemical synthesis BILLERICA, Mass. — MilliporeSigma today announced the acquisition of Grzybowski Scientific Inventions (GSI), a company that developed the revolutionary computer-aided retro-synthesis tool, Chematica. Chematica uses advanced reaction […]
Goldfinch Bio’s researchers select StarDrop to guide successful drug discovery CAMBRIDGE, UK and CAMBRIDGE, MA – Optibrium, a developer of software for small molecule discovery, and Goldfinch Bio, a company focused on discovering and developing precision therapies to treat patients with kidney disease, today announced that the company has signed a multi-year agreement to license Optibrium’s […]
Drug discovery software specialists combine expertise to extend studies into drug metabolism modelling CAMBRIDGE and LEEDS, UK – Optibrium™ and Lhasa Limited (Lhasa), developers of software for small molecule property prediction, design and optimisation, announced today they have formed a collaborative partnership to research next generation drug metabolism modelling. Results from the work will be […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
